TREX1 and autoimmune disease: Meanwhile, the tested results in other signaling pathways showed that compound 2 was a selective inhibitor of cGAS and reduced the mRNA level of IFN-β in bone marrow derived macrophages (BMDM) of AGS model TREX1-/- mice, thus indicating the potential for the treatment of autoimmune diseases.